Latest Breaking News On - Angelos stergiou - Page 9 : comparemela.com

SELLAS Life Sciences Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S in Acute Myeloid Leukemia

SELLAS Life Sciences Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S in Acute Myeloid Leukemia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Bruce mackleLife sciences group incGenfleet therapeutics shanghai incLife sciences provides update on phaseData monitoring committeeD medicines incLifesci advisorsMemorial sloan kettering cancer centerSciences provides updateAcute myeloidChina expectedSciences groupGreater chinaIndependent data monitoring committeeAngelos stergiouChief executive officer

SELLAS Life Sciences (SLS) Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S

SELLAS Life Sciences (SLS) Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Angelos stergiouSellas life sciences group incData monitoring committeeD medicines incSciences groupGreater chinaIndependent data monitoring committeeChief executive officer

SELLAS Life Sciences Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S in

- Enrollment ex-China Expected to be Completed in November 2023 –

Angelos stergiouBruce mackleMemorial sloan kettering cancer centerData monitoring committeeLife sciences group incD medicines incLifesci advisorsGenfleet therapeutics shanghai incChina expectedSciences groupGreater chinaIndependent data monitoring committeeChief executive officerGenfleet therapeuticsAnnual reportSci advisors

SELLAS Life Sciences Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S in Acute Myeloid Leukemia

Bruce mackleD medicines incLifesci advisorsMemorial sloan kettering cancer centerLife sciences group incGenfleet therapeutics shanghai incLife sciences provides update on phaseData monitoring committeeSciences provides updateAcute myeloidChina expectedSciences groupGreater chinaIndependent data monitoring committeeAngelos stergiouChief executive officer

SELLAS Announces First Patient Dosed in Phase Ib/II Trial of SLS009 (GFH009) in Relapsed/Refractory Peripheral T-cell Lymphomas

SELLAS Announces First Patient Dosed in Phase Ib/II Trial of SLS009 (GFH009) in Relapsed/Refractory Peripheral T-cell Lymphomas
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongBruce mackleAngelos stergiouGenfleet therapeutics shanghai incMemorial sloan kettering cancer centerGenfleet terapeutics shanghai incLife sciences group incLifesci advisorsFirst patient dosedRefractory peripheralt cellSciences groupGenfleet therapeuticsPeripheralt cell lymphomasChief executive officerGenfleet terapeutics